We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+19.09%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.27B
AUM Growth
-$5.76B
Cap. Flow
-$1.51B
Cap. Flow %
-46.09%
Top 10 Hldgs %
34.23%
Holding
5,681
New
749
Increased
1,274
Reduced
3,081
Closed
446

Sector Composition

Rank Sector Weight
1 Technology 9.66%
2 Financials 8.46%
3 Healthcare 8.24%
4 Consumer Discretionary 7.74%
5 Industrials 6.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDWD icon
4151
MediWound
MDWD
$179M
$13K ﹤0.01%
506
+445
+730% +$11.5K
MUX icon
4152
McEwen Inc
MUX
$1.17B
$13K ﹤0.01%
1,342
-2,698
-67% -$27.6K
NREF
4153
NexPoint Real Estate Finance
NREF
$313M
$13K ﹤0.01%
775
+673
+660% +$10.5K
NTST
4154
NETSTREIT Corp
NTST
$2.02B
$13K ﹤0.01%
659
-1,698
-72% -$31.4K
PBHC icon
4155
Pathfinder Bancorp
PBHC
$102M
$13K ﹤0.01%
1,122
+902
+410% +$9.96K
PLBY icon
4156
Playboy Inc
PLBY
$163M
$13K ﹤0.01%
+1,216
New +$12.4K
AGPU
4157
Axe Compute Inc
AGPU
$92.1M
$13K ﹤0.01%
57
+46
+418% +$10.1K
QQQM icon
4158
Invesco NASDAQ 100 ETF
QQQM
$102B
$13K ﹤0.01%
+107
New +$13K
RSSS icon
4159
Research Solutions
RSSS
$70.9M
$13K ﹤0.01%
5,771
-24,115
-81% -$55.2K
SCHG icon
4160
Schwab US Large-Cap Growth ETF
SCHG
$62.7B
$13K ﹤0.01%
808
+800
+10,000% +$12.1K
SLNO
4161
DELISTED
Soleno Therapeutics
SLNO
$13K ﹤0.01%
456
-2,036
-82% -$58.8K
SMHI icon
4162
SEACOR Marine Holdings
SMHI
$264M
$13K ﹤0.01%
4,777
+894
+23% +$1.89K
SND icon
4163
Smart Sand
SND
$200M
$13K ﹤0.01%
+7,690
New +$12.5K
STRM
4164
DELISTED
Streamline Health Solutions
STRM
$13K ﹤0.01%
576
+79
+16% +$1.83K
TRVI icon
4165
Trevi Therapeutics
TRVI
$2.54B
$13K ﹤0.01%
5,228
+3,821
+272% +$12.4K
TUR icon
4166
iShares MSCI Turkey ETF
TUR
$215M
$13K ﹤0.01%
477
+257
+117% +$5.61K
VITL icon
4167
Vital Farms
VITL
$496M
$13K ﹤0.01%
494
-1,332
-73% -$42.1K
VNQ icon
4168
Vanguard Real Estate ETF
VNQ
$38.3B
$13K ﹤0.01%
154
-94,435
-100% -$7.83M
YCBD icon
4169
cbdMD
YCBD
$6.14M
$13K ﹤0.01%
13
+7
+117% +$6.36K
LOGC
4170
DELISTED
ContextLogic
LOGC
$13K ﹤0.01%
+23
New +$14.2K
VCNX
4171
DELISTED
Vaccinex, Inc. Common Stock
VCNX
$13K ﹤0.01%
+30
New +$12.6K
DXYN
4172
DELISTED
Dixie Group Inc
DXYN
$13K ﹤0.01%
4,902
+195
+4% +$331
SCX
4173
DELISTED
The L.S. Starrett Company
SCX
$13K ﹤0.01%
3,026
+2,292
+312% +$7.99K
MOTS
4174
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
$13K ﹤0.01%
+45
New +$12.1K
SQZ
4175
DELISTED
SQZ Biotechnologies Company
SQZ
$13K ﹤0.01%
+432
New +$11K

Similar funds

Tower Research Capital (TRC)'s Q4 2020 Portfolio in Review

As of Q4 2020, Tower Research Capital (TRC) held 5,681 positions worth $3.27B, down 64% from $9.03B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $1.51B in Q4 2020, closing 446 positions and reducing 3,081 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $13.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 6.3% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 ETF worth $24.4M.

  • Tower Research Capital (TRC)'s largest Q4 2020 buy was iShares Russell 1000 ETF: 115,321 shares worth $24.4M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $99.8M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2020 reduction was iShares Russell 2000 ETF, cutting an estimated $36.3M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q4 2020, selling an estimated $13.7M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $3.27B portfolio in Q4 2020.
  • Tower Research Capital (TRC) opened 749 new positions and closed 446 in Q4 2020.
  • Tower Research Capital (TRC)'s portfolio value fell 64% quarter-over-quarter to $3.27B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2020, filed 16 Feb 2021.